Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 4
1947 4
1948 2
1949 5
1951 6
1952 2
1953 3
1954 6
1955 5
1956 6
1957 6
1958 5
1959 1
1960 3
1961 3
1962 3
1963 12
1964 20
1965 14
1966 7
1967 23
1968 31
1969 33
1970 59
1971 42
1972 63
1973 70
1974 58
1975 53
1976 47
1977 27
1978 28
1979 37
1980 36
1981 41
1982 36
1983 43
1984 57
1985 48
1986 40
1987 28
1988 50
1989 49
1990 44
1991 52
1992 47
1993 48
1994 47
1995 45
1996 59
1997 38
1998 53
1999 33
2000 45
2001 55
2002 64
2003 79
2004 92
2005 118
2006 114
2007 141
2008 163
2009 195
2010 189
2011 212
2012 223
2013 224
2014 239
2015 250
2016 221
2017 231
2018 226
2019 193
2020 30
Text availability
Article attribute
Article type
Publication date

Search Results

4,394 results
Results by year
Filters applied: . Clear all
Page 1
Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial.
Alistar A, Morris BB, Desnoyer R, Klepin HD, Hosseinzadeh K, Clark C, Cameron A, Leyendecker J, D'Agostino R Jr, Topaloglu U, Boteju LW, Boteju AR, Shorr R, Zachar Z, Bingham PM, Ahmed T, Crane S, Shah R, Migliano JJ, Pardee TS, Miller L, Hawkins G, Jin G, Zhang W, Pasche B. Alistar A, et al. Lancet Oncol. 2017 Jun;18(6):770-778. doi: 10.1016/S1470-2045(17)30314-5. Epub 2017 May 8. Lancet Oncol. 2017. PMID: 28495639 Free PMC article. Clinical Trial.
Associations between longitudinal serum perfluoroalkyl substance (PFAS) levels and measures of thyroid hormone, kidney function, and body mass index in the Fernald Community Cohort.
Blake BE, Pinney SM, Hines EP, Fenton SE, Ferguson KK. Blake BE, et al. Environ Pollut. 2018 Nov;242(Pt A):894-904. doi: 10.1016/j.envpol.2018.07.042. Epub 2018 Jul 17. Environ Pollut. 2018. PMID: 30373035 Free PMC article.
They persisted.
Talpos S. Talpos S. Science. 2019 May 17;364(6441):622-626. doi: 10.1126/science.364.6441.622. Science. 2019. PMID: 31097649 No abstract available.
Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial.
Gillingham MB, Heitner SB, Martin J, Rose S, Goldstein A, El-Gharbawy AH, Deward S, Lasarev MR, Pollaro J, DeLany JP, Burchill LJ, Goodpaster B, Shoemaker J, Matern D, Harding CO, Vockley J. Gillingham MB, et al. J Inherit Metab Dis. 2017 Nov;40(6):831-843. doi: 10.1007/s10545-017-0085-8. Epub 2017 Sep 4. J Inherit Metab Dis. 2017. PMID: 28871440 Free PMC article. Clinical Trial.
Ligand binding to human prostaglandin E receptor EP4 at the lipid-bilayer interface.
Toyoda Y, Morimoto K, Suno R, Horita S, Yamashita K, Hirata K, Sekiguchi Y, Yasuda S, Shiroishi M, Shimizu T, Urushibata Y, Kajiwara Y, Inazumi T, Hotta Y, Asada H, Nakane T, Shiimura Y, Nakagita T, Tsuge K, Yoshida S, Kuribara T, Hosoya T, Sugimoto Y, Nomura N, Sato M, Hirokawa T, Kinoshita M, Murata T, Takayama K, Yamamoto M, Narumiya S, Iwata S, Kobayashi T. Toyoda Y, et al. Nat Chem Biol. 2019 Jan;15(1):18-26. doi: 10.1038/s41589-018-0131-3. Epub 2018 Dec 3. Nat Chem Biol. 2019. PMID: 30510193
4,394 results
Jump to page
Feedback